The ALL disease was characterised by the absence of myeloid markers CD11b and Gr-1, and the expression of high levels of either CD19 or B220 on leukaemic blasts (Fig. 3a, c) as well as positive staining for CD3 by IHC (Fig. 3d). The gene discussed is ITGAM; the disease is acute lymphoblastic leukemia.